A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1995-03

AUTHORS

Gordon L. Amidon, Hans Lennernäs, Vinod P. Shah, John R. Crison

ABSTRACT

A biopharmaceutics drug classification scheme for correlating in vitro drug product dissolution and in vivo bioavailability is proposed based on recognizing that drug dissolution and gastrointestinal permeability are the fundamental parameters controlling rate and extent of drug absorption. This analysis uses a transport model and human permeability results for estimating in vivo drug absorption to illustrate the primary importance of solubility and permeability on drug absorption. The fundamental parameters which define oral drug absorption in humans resulting from this analysis are discussed and used as a basis for this classification scheme. These Biopharmaceutic Drug Classes are defined as: Case 1. High solubility-high permeability drugs, Case 2. Low solubility-high permeability drugs, Case 3. High solubility-low permeability drugs, and Case 4. Low solubility-low permeability drugs. Based on this classification scheme, suggestions are made for setting standards for in vitro drug dissolution testing methodology which will correlate with the in vivo process. This methodology must be based on the physiological and physical chemical properties controlling drug absorption. This analysis points out conditions under which no in vitro-in vivo correlation may be expected e.g. rapidly dissolving low permeability drugs. Furthermore, it is suggested for example that for very rapidly dissolving high solubility drugs, e.g. 85% dissolution in less than 15 minutes, a simple one point dissolution test, is all that may be needed to insure bioavailability. For slowly dissolving drugs a dissolution profile is required with multiple time points in systems which would include low pH, physiological pH, and surfactants and the in vitro conditions should mimic the in vivo processes.(ABSTRACT TRUNCATED AT 250 WORDS) More... »

PAGES

413-420

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1023/a:1016212804288

DOI

http://dx.doi.org/10.1023/a:1016212804288

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1037126380

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/7617530


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biological Availability", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cimetidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gastric Emptying", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "In Vitro Techniques", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Jejunum", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mathematics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Models, Theoretical", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Permeability", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pharmaceutical Preparations", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Piroxicam", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Solubility", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Michigan\u2013Ann Arbor", 
          "id": "https://www.grid.ac/institutes/grid.214458.e", 
          "name": [
            "College of Pharmacy, The University of Michigan, 48109-1065, Ann Arbor, Michigan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Amidon", 
        "givenName": "Gordon L.", 
        "id": "sg:person.014127067437.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014127067437.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Uppsala University", 
          "id": "https://www.grid.ac/institutes/grid.8993.b", 
          "name": [
            "School of Pharmacy, Uppsala University, Box 580, S-751 23, Uppsala, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lennern\u00e4s", 
        "givenName": "Hans", 
        "id": "sg:person.01372131203.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372131203.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Parenteral Drug Association", 
          "id": "https://www.grid.ac/institutes/grid.479064.8", 
          "name": [
            "PDA, HFD-602, 20857, Rockville, Maryland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shah", 
        "givenName": "Vinod P.", 
        "id": "sg:person.01223074603.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01223074603.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "TSRL (United States)", 
          "id": "https://www.grid.ac/institutes/grid.281449.2", 
          "name": [
            "TSRL, Inc., 540 Avis Drive, Suite A, 48108, Ann Arbor, Michigan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Crison", 
        "givenName": "John R.", 
        "id": "sg:person.015752121734.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015752121734.07"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1023/a:1018999130076", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002102293", 
          "https://doi.org/10.1023/a:1018999130076"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.2600750202", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003026689"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.2600691204", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010541473"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.1994.tb04309.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013748502"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.2600730922", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016268446"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0378-5173(89)90069-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024346420"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0378-5173(89)90069-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024346420"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/10611869509015945", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027004040"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.1993.tb05691.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028323223"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/gut.27.8.886", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034298308"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1015892621261", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035241234", 
          "https://doi.org/10.1023/a:1015892621261"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01061761", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036555799", 
          "https://doi.org/10.1007/bf01061761"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1015909716312", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038769588", 
          "https://doi.org/10.1023/a:1015909716312"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/03639048309046315", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039109681"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1015888813741", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040826363", 
          "https://doi.org/10.1023/a:1015888813741"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1015927004752", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042556047", 
          "https://doi.org/10.1023/a:1015927004752"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.2600781111", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042647529"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00562664", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044388678", 
          "https://doi.org/10.1007/bf00562664"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00562664", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044388678", 
          "https://doi.org/10.1007/bf00562664"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0378-5173(80)90048-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045925554"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0378-5173(80)90048-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045925554"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1015829128646", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047482208", 
          "https://doi.org/10.1023/a:1015829128646"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1018947113238", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051994422", 
          "https://doi.org/10.1023/a:1018947113238"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076536863", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0016-5085(90)91150-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078478659"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1995-03", 
    "datePublishedReg": "1995-03-01", 
    "description": "A biopharmaceutics drug classification scheme for correlating in vitro drug product dissolution and in vivo bioavailability is proposed based on recognizing that drug dissolution and gastrointestinal permeability are the fundamental parameters controlling rate and extent of drug absorption. This analysis uses a transport model and human permeability results for estimating in vivo drug absorption to illustrate the primary importance of solubility and permeability on drug absorption. The fundamental parameters which define oral drug absorption in humans resulting from this analysis are discussed and used as a basis for this classification scheme. These Biopharmaceutic Drug Classes are defined as: Case 1. High solubility-high permeability drugs, Case 2. Low solubility-high permeability drugs, Case 3. High solubility-low permeability drugs, and Case 4. Low solubility-low permeability drugs. Based on this classification scheme, suggestions are made for setting standards for in vitro drug dissolution testing methodology which will correlate with the in vivo process. This methodology must be based on the physiological and physical chemical properties controlling drug absorption. This analysis points out conditions under which no in vitro-in vivo correlation may be expected e.g. rapidly dissolving low permeability drugs. Furthermore, it is suggested for example that for very rapidly dissolving high solubility drugs, e.g. 85% dissolution in less than 15 minutes, a simple one point dissolution test, is all that may be needed to insure bioavailability. For slowly dissolving drugs a dissolution profile is required with multiple time points in systems which would include low pH, physiological pH, and surfactants and the in vitro conditions should mimic the in vivo processes.(ABSTRACT TRUNCATED AT 250 WORDS)", 
    "genre": "research_article", 
    "id": "sg:pub.10.1023/a:1016212804288", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2511825", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2508276", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1094644", 
        "issn": [
          "0724-8741", 
          "1573-904X"
        ], 
        "name": "Pharmaceutical Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "name": "A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability", 
    "pagination": "413-420", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "b0db9cc6ccd51802b1e31cfa7c11aabc5ba1c73ba893c97a211d72b1b27abceb"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "7617530"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8406521"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1023/a:1016212804288"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1037126380"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1023/a:1016212804288", 
      "https://app.dimensions.ai/details/publication/pub.1037126380"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T16:41", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8669_00000506.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1023/A:1016212804288"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1023/a:1016212804288'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1023/a:1016212804288'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1023/a:1016212804288'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1023/a:1016212804288'


 

This table displays all metadata directly associated to this object as RDF triples.

221 TRIPLES      21 PREDICATES      62 URIs      32 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1023/a:1016212804288 schema:about N0bcf548f40ab4db885ee8d601dad6046
2 N2725f506640b490fa2fa7b44d7d7c63c
3 N37d8cce4872d49bb82c5aa374e46e6a9
4 N4c473900cb1f4ac09c63cf9b56c28e32
5 N5f1d5a4ec5904dfa9a1abffba1e6c36f
6 N6c7c8ebf94724d83829395a8d6958827
7 N7c2b16fcd78d4036bb591328c327202b
8 Nb218c80ceac44b82b6490cdb1f8874d3
9 Nc8837ff2a8a1449593d0044ecf89b31a
10 Nca1c82ae14f044399b16cc90f2c86401
11 Nd581d1276ae24f3e91e7ef440d1f60fd
12 anzsrc-for:11
13 anzsrc-for:1115
14 schema:author N34a2ece2f5a74661bec9b194f0d97288
15 schema:citation sg:pub.10.1007/bf00562664
16 sg:pub.10.1007/bf01061761
17 sg:pub.10.1023/a:1015829128646
18 sg:pub.10.1023/a:1015888813741
19 sg:pub.10.1023/a:1015892621261
20 sg:pub.10.1023/a:1015909716312
21 sg:pub.10.1023/a:1015927004752
22 sg:pub.10.1023/a:1018947113238
23 sg:pub.10.1023/a:1018999130076
24 https://app.dimensions.ai/details/publication/pub.1076536863
25 https://doi.org/10.1002/jps.2600691204
26 https://doi.org/10.1002/jps.2600730922
27 https://doi.org/10.1002/jps.2600750202
28 https://doi.org/10.1002/jps.2600781111
29 https://doi.org/10.1016/0016-5085(90)91150-5
30 https://doi.org/10.1016/0378-5173(80)90048-4
31 https://doi.org/10.1016/0378-5173(89)90069-0
32 https://doi.org/10.1111/j.1365-2125.1993.tb05691.x
33 https://doi.org/10.1111/j.1365-2125.1994.tb04309.x
34 https://doi.org/10.1136/gut.27.8.886
35 https://doi.org/10.3109/03639048309046315
36 https://doi.org/10.3109/10611869509015945
37 schema:datePublished 1995-03
38 schema:datePublishedReg 1995-03-01
39 schema:description A biopharmaceutics drug classification scheme for correlating in vitro drug product dissolution and in vivo bioavailability is proposed based on recognizing that drug dissolution and gastrointestinal permeability are the fundamental parameters controlling rate and extent of drug absorption. This analysis uses a transport model and human permeability results for estimating in vivo drug absorption to illustrate the primary importance of solubility and permeability on drug absorption. The fundamental parameters which define oral drug absorption in humans resulting from this analysis are discussed and used as a basis for this classification scheme. These Biopharmaceutic Drug Classes are defined as: Case 1. High solubility-high permeability drugs, Case 2. Low solubility-high permeability drugs, Case 3. High solubility-low permeability drugs, and Case 4. Low solubility-low permeability drugs. Based on this classification scheme, suggestions are made for setting standards for in vitro drug dissolution testing methodology which will correlate with the in vivo process. This methodology must be based on the physiological and physical chemical properties controlling drug absorption. This analysis points out conditions under which no in vitro-in vivo correlation may be expected e.g. rapidly dissolving low permeability drugs. Furthermore, it is suggested for example that for very rapidly dissolving high solubility drugs, e.g. 85% dissolution in less than 15 minutes, a simple one point dissolution test, is all that may be needed to insure bioavailability. For slowly dissolving drugs a dissolution profile is required with multiple time points in systems which would include low pH, physiological pH, and surfactants and the in vitro conditions should mimic the in vivo processes.(ABSTRACT TRUNCATED AT 250 WORDS)
40 schema:genre research_article
41 schema:inLanguage en
42 schema:isAccessibleForFree false
43 schema:isPartOf N0eb88995d43d4065ae7d1a4a857385ae
44 N52cf752c04554ab09c1ea974a3493dd0
45 sg:journal.1094644
46 schema:name A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability
47 schema:pagination 413-420
48 schema:productId N35410f408f054e92a590449d819447d6
49 Naec9e5efb6e64438a76a3cf7905cdc91
50 Nc49b23a95541441fbf93d8c63b204d90
51 Nd880b024ca5042ffa4f51e7ccad29920
52 Ne9a0d8c9fd994432bf07ca64c2d06dea
53 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037126380
54 https://doi.org/10.1023/a:1016212804288
55 schema:sdDatePublished 2019-04-10T16:41
56 schema:sdLicense https://scigraph.springernature.com/explorer/license/
57 schema:sdPublisher N08dd32e156fe4dc283bb20678bd0226c
58 schema:url http://link.springer.com/10.1023/A:1016212804288
59 sgo:license sg:explorer/license/
60 sgo:sdDataset articles
61 rdf:type schema:ScholarlyArticle
62 N08dd32e156fe4dc283bb20678bd0226c schema:name Springer Nature - SN SciGraph project
63 rdf:type schema:Organization
64 N0bcf548f40ab4db885ee8d601dad6046 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Piroxicam
66 rdf:type schema:DefinedTerm
67 N0eb88995d43d4065ae7d1a4a857385ae schema:issueNumber 3
68 rdf:type schema:PublicationIssue
69 N2725f506640b490fa2fa7b44d7d7c63c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Models, Theoretical
71 rdf:type schema:DefinedTerm
72 N34a2ece2f5a74661bec9b194f0d97288 rdf:first sg:person.014127067437.90
73 rdf:rest Na1e222e4533f47dbb139d7091b8111ce
74 N35410f408f054e92a590449d819447d6 schema:name nlm_unique_id
75 schema:value 8406521
76 rdf:type schema:PropertyValue
77 N37d8cce4872d49bb82c5aa374e46e6a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Solubility
79 rdf:type schema:DefinedTerm
80 N4c473900cb1f4ac09c63cf9b56c28e32 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Biological Availability
82 rdf:type schema:DefinedTerm
83 N52cf752c04554ab09c1ea974a3493dd0 schema:volumeNumber 12
84 rdf:type schema:PublicationVolume
85 N5f1d5a4ec5904dfa9a1abffba1e6c36f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Pharmaceutical Preparations
87 rdf:type schema:DefinedTerm
88 N6c7c8ebf94724d83829395a8d6958827 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Jejunum
90 rdf:type schema:DefinedTerm
91 N6f8e2ba487da407ab777e7e4757b2ba9 rdf:first sg:person.01223074603.31
92 rdf:rest N9caeff0abca9493b95f9ab846bc2b24a
93 N7c2b16fcd78d4036bb591328c327202b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Mathematics
95 rdf:type schema:DefinedTerm
96 N9caeff0abca9493b95f9ab846bc2b24a rdf:first sg:person.015752121734.07
97 rdf:rest rdf:nil
98 Na1e222e4533f47dbb139d7091b8111ce rdf:first sg:person.01372131203.73
99 rdf:rest N6f8e2ba487da407ab777e7e4757b2ba9
100 Naec9e5efb6e64438a76a3cf7905cdc91 schema:name doi
101 schema:value 10.1023/a:1016212804288
102 rdf:type schema:PropertyValue
103 Nb218c80ceac44b82b6490cdb1f8874d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Cimetidine
105 rdf:type schema:DefinedTerm
106 Nc49b23a95541441fbf93d8c63b204d90 schema:name pubmed_id
107 schema:value 7617530
108 rdf:type schema:PropertyValue
109 Nc8837ff2a8a1449593d0044ecf89b31a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name In Vitro Techniques
111 rdf:type schema:DefinedTerm
112 Nca1c82ae14f044399b16cc90f2c86401 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Gastric Emptying
114 rdf:type schema:DefinedTerm
115 Nd581d1276ae24f3e91e7ef440d1f60fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Permeability
117 rdf:type schema:DefinedTerm
118 Nd880b024ca5042ffa4f51e7ccad29920 schema:name readcube_id
119 schema:value b0db9cc6ccd51802b1e31cfa7c11aabc5ba1c73ba893c97a211d72b1b27abceb
120 rdf:type schema:PropertyValue
121 Ne9a0d8c9fd994432bf07ca64c2d06dea schema:name dimensions_id
122 schema:value pub.1037126380
123 rdf:type schema:PropertyValue
124 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
125 schema:name Medical and Health Sciences
126 rdf:type schema:DefinedTerm
127 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
128 schema:name Pharmacology and Pharmaceutical Sciences
129 rdf:type schema:DefinedTerm
130 sg:grant.2508276 http://pending.schema.org/fundedItem sg:pub.10.1023/a:1016212804288
131 rdf:type schema:MonetaryGrant
132 sg:grant.2511825 http://pending.schema.org/fundedItem sg:pub.10.1023/a:1016212804288
133 rdf:type schema:MonetaryGrant
134 sg:journal.1094644 schema:issn 0724-8741
135 1573-904X
136 schema:name Pharmaceutical Research
137 rdf:type schema:Periodical
138 sg:person.01223074603.31 schema:affiliation https://www.grid.ac/institutes/grid.479064.8
139 schema:familyName Shah
140 schema:givenName Vinod P.
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01223074603.31
142 rdf:type schema:Person
143 sg:person.01372131203.73 schema:affiliation https://www.grid.ac/institutes/grid.8993.b
144 schema:familyName Lennernäs
145 schema:givenName Hans
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372131203.73
147 rdf:type schema:Person
148 sg:person.014127067437.90 schema:affiliation https://www.grid.ac/institutes/grid.214458.e
149 schema:familyName Amidon
150 schema:givenName Gordon L.
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014127067437.90
152 rdf:type schema:Person
153 sg:person.015752121734.07 schema:affiliation https://www.grid.ac/institutes/grid.281449.2
154 schema:familyName Crison
155 schema:givenName John R.
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015752121734.07
157 rdf:type schema:Person
158 sg:pub.10.1007/bf00562664 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044388678
159 https://doi.org/10.1007/bf00562664
160 rdf:type schema:CreativeWork
161 sg:pub.10.1007/bf01061761 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036555799
162 https://doi.org/10.1007/bf01061761
163 rdf:type schema:CreativeWork
164 sg:pub.10.1023/a:1015829128646 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047482208
165 https://doi.org/10.1023/a:1015829128646
166 rdf:type schema:CreativeWork
167 sg:pub.10.1023/a:1015888813741 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040826363
168 https://doi.org/10.1023/a:1015888813741
169 rdf:type schema:CreativeWork
170 sg:pub.10.1023/a:1015892621261 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035241234
171 https://doi.org/10.1023/a:1015892621261
172 rdf:type schema:CreativeWork
173 sg:pub.10.1023/a:1015909716312 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038769588
174 https://doi.org/10.1023/a:1015909716312
175 rdf:type schema:CreativeWork
176 sg:pub.10.1023/a:1015927004752 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042556047
177 https://doi.org/10.1023/a:1015927004752
178 rdf:type schema:CreativeWork
179 sg:pub.10.1023/a:1018947113238 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051994422
180 https://doi.org/10.1023/a:1018947113238
181 rdf:type schema:CreativeWork
182 sg:pub.10.1023/a:1018999130076 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002102293
183 https://doi.org/10.1023/a:1018999130076
184 rdf:type schema:CreativeWork
185 https://app.dimensions.ai/details/publication/pub.1076536863 schema:CreativeWork
186 https://doi.org/10.1002/jps.2600691204 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010541473
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1002/jps.2600730922 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016268446
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1002/jps.2600750202 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003026689
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1002/jps.2600781111 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042647529
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1016/0016-5085(90)91150-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078478659
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1016/0378-5173(80)90048-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045925554
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1016/0378-5173(89)90069-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024346420
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1111/j.1365-2125.1993.tb05691.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1028323223
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1111/j.1365-2125.1994.tb04309.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1013748502
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1136/gut.27.8.886 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034298308
205 rdf:type schema:CreativeWork
206 https://doi.org/10.3109/03639048309046315 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039109681
207 rdf:type schema:CreativeWork
208 https://doi.org/10.3109/10611869509015945 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027004040
209 rdf:type schema:CreativeWork
210 https://www.grid.ac/institutes/grid.214458.e schema:alternateName University of Michigan–Ann Arbor
211 schema:name College of Pharmacy, The University of Michigan, 48109-1065, Ann Arbor, Michigan
212 rdf:type schema:Organization
213 https://www.grid.ac/institutes/grid.281449.2 schema:alternateName TSRL (United States)
214 schema:name TSRL, Inc., 540 Avis Drive, Suite A, 48108, Ann Arbor, Michigan
215 rdf:type schema:Organization
216 https://www.grid.ac/institutes/grid.479064.8 schema:alternateName Parenteral Drug Association
217 schema:name PDA, HFD-602, 20857, Rockville, Maryland
218 rdf:type schema:Organization
219 https://www.grid.ac/institutes/grid.8993.b schema:alternateName Uppsala University
220 schema:name School of Pharmacy, Uppsala University, Box 580, S-751 23, Uppsala, Sweden
221 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...